Barclays Maintains Overweight on Braze, Raises Price Target to $31

Benzinga Newsdesk www.benzinga.com Positive 83.0%

Neg 0% Neu 0% Pos 83%

Barclays analyst Raimo Lenschow maintains Braze (NASDAQ:BRZE) with a Overweight and raises the price target from $29 to $31.